[Federal Register Volume 68, Number 34 (Thursday, February 20, 2003)]
[Notices]
[Page 8299]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-4090]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 02N-0259]


Agency Information Collection Activities; Announcement of OMB 
Approval; Telephone Questionnaire Administration to Control Subjects 
Recruited into FDA Lyme Vaccine Safety Study, ``A Case-Control Study of 
HLA Type and T-Cell Reactivity to Recombinant Outer Surface Protein A 
and Human Leukocyte Function-Associated Antigen-1''

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled Telephone Questionnaire 
Administration to Control Subjects Recruited into FDA Lyme Vaccine 
Safety Study, ``A Case-Control Study of HLA Type and T-Cell Reactivity 
to Recombinant Outer Surface Protein A and Human Leukocyte Function-
Associated Antigen-1'' has been approved by the Office of Management 
and Budget (OMB) under the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: JonnaLynn P. Capezzuto, Office of 
Information Resources Management (HFA-250), Food and Drug 
Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-4659.

SUPPLEMENTARY INFORMATION: In the Federal Register of October 18, 2002 
(67 FR 64397), the agency announced that the proposed information 
collection had been submitted to OMB for review and clearance under 44 
U.S.C. 3507. An agency may not conduct or sponsor, and a person is not 
required to respond to, a collection of information unless it displays 
a currently valid OMB control number. OMB has now approved the 
information collection and has assigned OMB control number 0910-0501. 
The approval expires on June 30, 2004. A copy of the supporting 
statement for this information collection is available on the Internet 
at http://www.fda.gov/ohrms/dockets.

    Dated: February 10, 2003.
Margaret M. Dotzel,
Assistant Commissioner for Policy.
[FR Doc. 03-4090 Filed 2-19-03; 8:45 am]
BILLING CODE 4160-01-S